Efectivity of Non-invasive Neuromodulation in Parasympathic Nervous System and Vascular System
- Disease/Condition
- Hypertension
- Drug/Device/Intervention
- Non-Invasive neuromodulation
- Study type
- Interventional
- Intervention type
- device
- Primary sponsor
- Universidad Europea de Madrid
- Phase
- N/A
- Start date
- Mar 01, 2024
- End date
- Jun 01, 2024
- Enrollment
- 40 participants
Systolic and diastolic Blood Pressure:,Heart rate
The study, conducted by the Universidad Europea de Madrid, examines the immediate effects of
 a single session using NESA microcurrents on various circulatory system variables in healthy
 subjects. It divides participants into three groups based on session duration (15, 30, 45
 minutes), measuring pre and post-intervention changes. The focus is on autonomic nervous
 system responses, aiming to understand the minimum treatment characteristics needed for
 significant autonomic changes. Variables studied include systolic and diastolic blood
 pressure, heart rate, and several ultrasound measurements of the common carotid artery (CSA),
 including thickness and peak systolic flow velocity.
- Registry
- ClinicalTrials.gov
- Trial ID
- NCT06320171
- Type
- Device Trial
Access comprehensive clinical trial information for NCT06320171 through Pure Global AI's free database. This phase not specified trial is sponsored by Universidad Europea de Madrid and is currently Not yet recruiting. The study focuses on Hypertension. Target enrollment is 40 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.